Florence Healthcare vs Numerion Labs

Side-by-side comparison of AI visibility scores, market position, and capabilities

Florence Healthcare leads in AI visibility (74 vs 52)
Florence Healthcare logo

Florence Healthcare

LeaderLife Sciences & BioTech

Clinical Trial Site Enablement Platform

Florence Healthcare is the leading clinical trial site enablement platform, connecting 12,000+ research sites in 45 countries; $116M raised from Insight Partners; processes 6.5M+ research workflows monthly via remote digital document management.

AI VisibilityBeta
Overall Score
B74
Category Rank
#6 of 198
AI Consensus
75%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
71
Gemini
79

About

Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to streamline regulatory documentation, remote monitoring, and operational workflows. Founded in Atlanta and backed by Insight Partners, Florence has built the industry's largest connected network of clinical trial sites — over 12,000 sites across 45 countries — making it the infrastructure backbone for decentralized and hybrid clinical research.

Full profile
Numerion Labs logo

Numerion Labs

ChallengerLife Sciences & BioTech

AI-Driven Small Molecule Drug Discovery

Numerion Labs (fka Atomwise) deploys AtomNet deep learning for ultra-fast virtual drug screening; partnered with Sanofi for up to $1.2B in milestones; rebranded Oct 2025 with new APEX platform for hyper-scalable virtual library screening.

AI VisibilityBeta
Overall Score
C52
Category Rank
#68 of 198
AI Consensus
81%
Trend
stable
Per Platform
ChatGPT
51
Perplexity
49
Gemini
55

About

Numerion Labs, formerly known as Atomwise, is an AI-driven drug discovery company that uses deep learning to accelerate the identification of small molecule drug candidates. The company''s core technology, AtomNet, is a convolutional neural network trained on vast datasets of protein-ligand interactions to predict binding affinity and drug-likeness at scale. In October 2025, Atomwise rebranded as Numerion Labs, reflecting a sharpened strategic focus on ultra-fast virtual screening and the development of its APEX platform for hyper-scalable chemical library screening — a capability validated in partnership with NVIDIA.

Full profile

AI Visibility Head-to-Head

74
Overall Score
52
#6
Category Rank
#68
75
AI Consensus
81
stable
Trend
stable
80
ChatGPT
51
71
Perplexity
49
79
Gemini
55
74
Claude
47
72
Grok
52

Key Details

Category
Clinical Trial Site Enablement Platform
AI-Driven Small Molecule Drug Discovery
Tier
Leader
Challenger
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.